protease inhibitor

DRUG3 trials

Sponsors

French National Agency for Research on AIDS and Viral Hepatitis, Medical Research Council, ANRS, Emerging Infectious Diseases

Conditions

Acquired Immunodeficiency SyndromeHIV InfectionHIV InfectionsHIV-1 InfectionHIV-Associated Lipodystrophy SyndromeTreatment Resistant DisordersViremia

Phase 3

Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)

TerminatedNCT02247687

ANRS, Emerging Infectious DiseasesHIV-1 Infection, Treatment Resistant Disorders, Viremia

Start: 2014-12-31End: 2015-09-30Updated: 2015-10-12

Phase 4

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

TerminatedNCT00122668

French National Agency for Research on AIDS and Viral HepatitisHIV-Associated Lipodystrophy Syndrome, HIV Infections

Start: 2003-11-30End: 2005-07-31Target: 112Updated: 2005-11-15

Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)

Medical Research CouncilAcquired Immunodeficiency Syndrome, HIV Infection

Start: 2008-11-30End: 2013-11-30Updated: 2012-10-10

Related Papers

Neurocognitive function in HIV infected patients on antiretroviral therapy.

2013-04-3057 citations